Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.
Yuichi MaedaToru HiranoKosuke EbinaRyota HaraMotomu HashimotoWataru YamamotoKosaku MurakamiTakuya KotaniKenichiro HataYonsu SonHideki AmuroAkira OnishiSadao JinnoMasaki KatayamaAtsushi KumanogohPublished in: Rheumatology international (2021)
aIL-6 was more effective in the patients with RA and knee joint involvement, compared to other bDMARDs.